Antileishmanial Action of Tephrosia purpurea Linn, Extract and Its Fractions Against Experimental Visceral Leishmaniasis

Drug Development Research

Volumn 60, Issue 4, 2003, Pages 285-293

  Sharma, Preeti ^a   Rastogi, Subha ^a   Bhatnagar, Sunita ^a   Srivastava, Janmejya K ^a   Dube, Anuradha ^a   Guru, Purushottam Y ^a   Kulshrestha, Dinesh K ^a   Mehrotra, Bishan N ^a   Dhawan, Bhola N ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Golden hamsters; Leishmania donovani; Presbytis entellus; Tephrosia purpurea

Indexed keywords

ANTILEISHMANIAL AGENT; BUTANOL; PLANT EXTRACT; TEPHROSIA PURPUREA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTILEISHMANIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HAMSTER; LEISHMANIA DONOVANI; LEISHMANIASIS; MALE; MEDICINAL PLANT; MONKEY; NONHUMAN; STATISTICAL SIGNIFICANCE; TEPHROSIA; TEPHROSIA PURPUREA;

EID: 0344012560     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10324     Document Type: Article

References (22)

1. Anuradha Pal R, Zehra K, Katiyar JC, Sethi N, Bhatia G, Singh RK. 1992. The Indian langur: preliminary report of a new non-human primate host for visceral leishmaniasis. Bull World Health Organ 70:63-72.
2. Berman JD. 1988. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy and future strategies. Rev Infect Dis 10:560-586.
3. Chatterjee SN, Ghose MP. 1955. Observation on the degree of splenic and hepatic enlargement in kala-azar and tropical splenomegaly. Ind Med Assoc 11:435.
4. Chopra RN, Chopra IC, Handa KL, Kapur LD. 1958. Indigenous drugs of India. Calcutta, India U.N Dhar and Sons Pvt. p. 9.
5. Engvall E, Perlmann P. 1972. Enzyme-linked immunosorbent assay (ELISA). Quantitation of specific antibodies by enzyme labelled anti-immunoglobulin in antigen coated tubes. J Immunol 109:129-135.
6. Guru PY, Agarwal AK, Singha UK, Singhal A, Gupta CM. 1989. Drug targeting in Leishmania donovani infections using tuftsin-bearing liposomes as drug vehicles. FEBS Lett 245:204-208.
7. Guru PY, Singh SN, Chatterjee RK, Dhawan BN, Kamboj VP. 1996. Traditional remedies in the management of parasitic diseases. Proc Natl Acad Sci India 66(B)(spl. issue):243-273.
8. Jha TK, Olliaro P, Thakur CPN, et al. 1998. Randomised controlled trial of aminosidine (Paromomycin) v. sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. BMJ 361:1200-1205.
9. Jha TK, Sundar S, Thakur CP, Bachmann P, Karbwang J, Fischer C, Voss A, Berman J. 1999. Efficacy and toxicity of miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med 341:1795-1800.
10. Murray HW, Hariprasad J, Richard EF. 1993. Treatment of experimental visceral leishmaniasis in a 'T' cell-deficient host: response to amphotericin B and pentamidine. Antimicrob Agents Chemother 37:1504-1505.
11. Nadkarni AK. 1954. Indian materia medica 1. Bombay, India: Popular Book Dept. p. 25.
12. Neal RA, Croft SL. 1984. An in vitro system for determining the activity of compounds against the intracellular amastigote form of L. donovani. J Antimicrob Chemother 14:463-475.
13. Olliaro PL, Bryceson ADM. 1993. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol Today 9:323-328.
14. Sacks DL, Lal SL, Shrivastava SN, Blackwell J, Neva FA. 1987. An analysis of 'T' cell responsiveness in Indian kala-azar. J Immunol 138:908-913.
15. Sen Gupta PC, Chakravarty NK, Ray HN, Das Gupta B. 1956. The liver in kala-azar. Ann Trop Med Parasitol 50:252-259.
16. Stauber LA, Franchino EM, Grun J. 1958. An eight-day method for screening compounds against Leishmania donovani in golden hamsters. J Protozool 5:269-273.
17. Sundar S. 2001. Treatment of visceral leishmaniasis. Med Microbiol Immunol (Berl) 190:89-92.
18. Sundar S, Agrawal NK, Sinha PK, Horwith GS, Murray HW. 1997. Short-course, low-dose amphotericin B lipid complex therapy for antimony-unresponsive visceral leishmaniasis (kala-azar) in India. Ann Intern Med 127:133-137.
19. Sundar S, Makharia A, More DK, Agrawal G, Voss A, Fischer C, Bachmann P, Murray HW. 2000. Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clin Infect Dis 31:1110-1113.
20. Thakur CP. 1986. Harmful effect of high stibogluconate treatment of kala-azar in India. Trans R Soc Trop Med Hyg 80:672-673.
21. Thakur CP. 1993. Treatment of kala-azar and post kala-azar dermal leishmaniasis in India [Abstract]. III Asian Congress of Parasitology, Lucknow, India, 18-21, Feb.
22. World Health Organization 1990. Antimonials: large scale failure in leishmaniasis alarming. Trop Dis Rep 34:1-7.